Publisher Correction

None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None; None, None

Publisher Correction

LifeTime and improving European healthcare through cell-based interceptive medicine (Nature, (2020), 587, 7834, (377-386), 10.1038/s41586-020-2715-9)

Journal Article (2020)

Author(s)

Nikolaus Rajewsky (Partner site Griefswald, Charité Universittsmedizin Berlin, Max-Delbrück-Center for Molecular Medicine and Charité Universitätsmedizin Berlin, Berlin Institute of Health (BIH))

Geneviève Almouzni (Institut Curie)

Stanislaw A. Gorski (Max-Delbrück-Center for Molecular Medicine and Charité Universitätsmedizin Berlin)

Stein Aerts (VIB, Katholieke Universiteit Leuven)

Ido Amit (Weizmann Institute of Science)

Michela G. Bertero (Barcelona Institute of Science and Technology (BIST))

Christoph Bock (Ludwig Boltzmann Institute, Austrian Academy of Sciences, Medical University of Vienna)

Annelien L. Bredenoord ( University Medical Centre Utrecht)

Giacomo Cavalli (Université Montpellier II)

Susanna Chiocca (European Institute of Oncology IRCCS)

Hans Clevers (Oncode Institute, University Medical Centre Utrecht, Princess Máxima Center for Pediatric Oncology)

Bart De Strooper (VIB, University College London, Katholieke Universiteit Leuven)

Angelika Eggert (Berlin Institute of Health (BIH), Charité Universittsmedizin Berlin)

Jan Ellenberg (European Molecular Biology Laboratory)

Xosé M. Fernández (Institut Curie)

Marek Figlerowicz (Poznan University of Technology, Polish Academy of Sciences)

Susan M. Gasser (Friedrich Miescher Institute for Biomedical Research, University of Basel)

Norbert Hubner (Berlin Institute of Health (BIH), Partner site Griefswald, Charité Universittsmedizin Berlin, Max-Delbrück-Center for Molecular Medicine and Charité Universitätsmedizin Berlin)

Jørgen Kjems (Aarhus University)

Jürgen A. Knoblich (Medical University of Vienna, Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA))

Grietje Krabbe (Max-Delbrück-Center for Molecular Medicine and Charité Universitätsmedizin Berlin)

Peter Lichter (German Cancer Research Center)

Sten Linnarsson (Karolinska Institutet, Science for Life Laboratory)

Jean Christophe Marine (Katholieke Universiteit Leuven)

John C. Marioni (European Bioinformatics Institute, University of Cambridge, Wellcome Sanger Institute)

Marc A. Marti-Renom (Barcelona Institute of Science and Technology, Catalan Institution for Research and Advanced Studies (ICREA), Barcelona Institute of Science and Technology (BIST), Pompeu Fabra University)

Mihai G. Netea (Universität Bonn, Radboud University Medical Center)

Dörthe Nickel (Institut Curie)

Marcelo Nollmann (Centre de Biochimie Structurale)

Halina R. Novak (VIB Technology Watch)

Helen Parkinson (European Bioinformatics Institute)

Stefano Piccolo (The FIRC Institute of Molecular Oncology, Università degli Studi di Padova)

Inês Pinheiro (Institut Curie)

Ana Pombo (Max-Delbrück-Center for Molecular Medicine and Charité Universitätsmedizin Berlin, Humboldt-Universitat zu Berlin)

Christian Popp (Max-Delbrück-Center for Molecular Medicine and Charité Universitätsmedizin Berlin)

Wolf Reik (University of Cambridge, Babraham Institute, Wellcome Sanger Institute)

Sergio Roman-Roman (Institut Curie)

Philip Rosenstiel (University Hospital Schleswig-Holstein, Christian-Albrechts-Universität zu Kiel)

Joachim L. Schultze (German Center for Neurodegenerative Diseases (DZNE), Universität Bonn)

Oliver Stegle (European Bioinformatics Institute, European Molecular Biology Laboratory, German Cancer Research Center, Wellcome Sanger Institute)

Amos Tanay (Weizmann Institute of Science)

Giuseppe Testa (University of Milan, Human Technopole, European Institute of Oncology IRCCS)

Dimitris Thanos (Biomedical Research Foundation of the Academy of Athens)

Fabian J. Theis (Technische Universität München, Helmholtz Zentrum München)

Maria Elena Torres-Padilla (Ludwig Maximilians University, Helmholtz Zentrum München)

Alfonso Valencia (Barcelona Supercomputing Center, Catalan Institution for Research and Advanced Studies (ICREA))

Céline Vallot (Institut Curie)

Alexander van Oudenaarden ( University Medical Centre Utrecht, Oncode Institute)

Marie Vidal (Max-Delbrück-Center for Molecular Medicine and Charité Universitätsmedizin Berlin)

Ibo van de Poel (TU Delft - Technology, Policy and Management)

Contributor(s)

Research Group

Ethics & Philosophy of Technology

DOI related publication

https://doi.org/10.1038/s41586-021-03287-8 Final published version

To reference this document use

https://resolver.tudelft.nl/uuid:783ff51b-b477-44d4-80a4-f8743014ec0f

More Info

expand_more

Publication Year

2020

Language

English

Research Group

Ethics & Philosophy of Technology

Journal title

Nature

Issue number

7852

Volume number

592

Pages (from-to)

E8

Downloads counter

547

Collections

Institutional Repository

Abstract

In this Perspective, owing to an error in the HTML, the surname of author Alejandro López-Tobón of the LifeTime Community Working Groups consortium was indexed as ‘Tobon’ rather than ‘López-Tobón’ and the accents were missing. The HTML version of the original Perspective has been corrected; the PDF and print versions were always correct.